Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Onconetix (ONCO) Profit After Tax (2023 - 2025)

Historic Profit After Tax for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to -$8.8 million.

  • Onconetix's Profit After Tax fell 12949.5% to -$8.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$49.1 million, marking a year-over-year increase of 477.33%. This contributed to the annual value of -$58.7 million for FY2024, which is 5688.72% down from last year.
  • According to the latest figures from Q3 2025, Onconetix's Profit After Tax is -$8.8 million, which was down 12949.5% from -$2.4 million recorded in Q2 2025.
  • Over the past 5 years, Onconetix's Profit After Tax peaked at -$2.4 million during Q2 2025, and registered a low of -$29.4 million during Q4 2024.
  • In the last 3 years, Onconetix's Profit After Tax had a median value of -$8.5 million in 2025 and averaged -$10.5 million.
  • In the last 5 years, Onconetix's Profit After Tax plummeted by 29058.53% in 2024 and then soared by 8341.73% in 2025.
  • Quarter analysis of 3 years shows Onconetix's Profit After Tax stood at -$22.4 million in 2023, then plummeted by 31.71% to -$29.4 million in 2024, then skyrocketed by 70.16% to -$8.8 million in 2025.
  • Its Profit After Tax stands at -$8.8 million for Q3 2025, versus -$2.4 million for Q2 2025 and -$8.5 million for Q1 2025.